FDA Panel Supports Pfizer Vaccine For Children 5-11

An FDA advisory panel has officially endorsed the Pfizer COVID-19 vaccine for children ages 5-11.

The panel made a unanimous decision on Tuesday, which now goes to the FDA for its final ruling, due sometime in the coming days.

If approved, the vaccine would be a smaller dose than the one given to adults – just 10 micrograms compared to 30 in the full vaccine.

Just like the adult vaccine, it would be given in two doses, three weeks apart.

NBC News Special Report:

FDA advisory panel recommends Pfizer’s Covid vaccine for emergency use in kids ages 5 to 11. https://t.co/EJGDy70cNOhttps://t.co/nBJo5fUTGW

— NBC News (@NBCNews) October 26, 2021